Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Osteonecrosis of the Femoral Head, Avascular Necrosis of the Femoral Head
In brief
Osteonecrosis of the femoral head (ONFH) is a debilitating musculoskeletal disease that is characterized by localized death of bone cells and associated cellular elements within the subchondral bone. If it progresses, it results in the collapse of the femoral head (ball part of the hip) giving rise to secondary arthritis. This condition is associated with marked pain and loss of function, often necessitating a joint replacement. Due to the relatively young age of onset of ONFH (often in 20s and 30s), there is great interest in utilizing joint-preserving procedures prior to the need for joint replacement. Joint-preserving procedures include core decompression (CD) with and without bone grafts or cells, vascularized and non-vascularized bone grafting, as well as osteotomies. Inconsistent results for each of these procedures have been reported and there are no Clinical Practice Guidelines or medical community consensus opinions regarding the treatment of early-stage ONFH. The hypothesis to be tested is "Participants who have early-stage ONFH undergoing CD augmented with autogenous bone marrow aspirate concentrate will have better clinical and radiological outcomes than CD alone." This multi-center randomized controlled trial for early-stage ONFH is prospective and controlled for participant stage (only early-stage pre-collapse individuals) and surgical technique. Participants will be evaluated as per routine surgical follow-up, and at 6 months (telemedicine), 1- and 2- years using radiographs, MRIs, and questionnaires. This project will also explore the scientific basis for success vs. failure in individuals who have osteonecrosis, and have different demographics and bone marrow aspirate cell profiles.
Key facts
- Study ID
- NCT06123481
- Run by
- Johns Hopkins University
- People needed
- 192
- Starts
- 2025-04-01
- Expected to finish
- 2029-07-31
- Last updated by the study team
- 2025-11-26
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants who have non-traumatic osteonecrosis of the femoral head
- Only participants who have Stage 1 or 2 osteonecrosis as assessed by the 2019 ARCO Staging System
- No evidence of subchondral fracture
- All osteonecrotic lesion sizes
- All major risk factors (e.g. corticosteroids, alcohol, organ recipient) except for those listed in the exclusion criteria
- Participants diagnosed who have femoral head osteonecrosis for which no risk factor has yet to be identified
- Participants will include all ethnicities and races
- Be able and willing to participate in study and return for postoperative visits
You may not qualify if…
- Participants who have:
- Sickle Cell disease
- Major trauma
- Post-irradiation ON
- Gaucher Disease
- Juvenile form: Legg-Calve-Perthes Disease
- Juvenile form: Spontaneous ON of the hip
- Pregnant or breastfeeding
- Vulnerable population; i.e., prisoners and institutionalized individuals
- Participant is unable to undergo an MRI
- Participants who have evidence of a subchondral fracture
- Prior history of hip surgery, more extensive than hip arthroscopy
Where it is running
- University of Southern California — Los Angeles, California, United States (enrolling)
- Stanford University — Stanford, California, United States (enrolling)
- Sinai Hospital of Baltimore — Baltimore, Maryland, United States (enrolling)
- Johns Hopkins University — Baltimore, Maryland, United States (enrolling)
- University of Minnesota — Minneapolis, Minnesota, United States (enrolling)
- Mayo Clinic — Rochester, Minnesota, United States (enrolling)
- NYU Langone Health Orthopedic Hospital — New York, New York, United States (enrolling)
- Cleveland Clinic — Cleveland, Ohio, United States (enrolling)
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
- University of Virginia — Charlottesville, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.